VEGFA and diabetic macular edema: One example of this is in the treatment of diabetic macular edema (DME) where anti-angiogenic agents which block vascular endothelial growth factor (anti-VEGF agents) delivered by intravitreous injection have shown greater efficacy than conventional macular laser in improving vision in eyes with DME.[1,2]